Status:
RECRUITING
Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
Lead Sponsor:
French Africa Pediatric Oncology Group
Collaborating Sponsors:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Staging
Therapeutic Recommendations
Eligibility:
All Genders
Up to 18 years
Brief Summary
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability o...
Detailed Description
In high-income countries, therapeutic outcomes exceed 90% and therapeutic de-escalation is necessary to reduce mainly the effects of long-term radiotherapy. Within the same country, there are also dif...
Eligibility Criteria
Inclusion
- under 18 years of age at diagnosis
- suffering from "classical" Hodgkin's disease according to the WHO classification.
- with no history of hematological malignancies or constitutional or acquired immune deficiencies
Exclusion
- Over 18 years of age at diagnosis
- A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Key Trial Info
Start Date :
November 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 20 2034
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05407480
Start Date
November 15 2022
End Date
November 20 2034
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brenda Mallon
Paris, France, France, 94805